Skip to content

Evaluation of Vidiac Scores of Obese and Morbid Obese Patients Intubated by Videolaryngoscopy

Evaluation of Vidiac Scores of Obese and Morbid Obese Patients Intubated by Videolaryngoscopy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05697744
Enrollment
82
Registered
2023-01-26
Start date
2023-02-28
Completion date
2023-09-30
Last updated
2023-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Morbid, Videolaryngoscopy, Vidiac Score

Brief summary

The aim of the study was to observe the vidiac score values of only patients with obesity as a risk factor for difficult intubation. Secondly, it was aimed to evaluate the number of intubation attempts and intubation time, vidiac scores between obese and morbid obese patients and to reveal the differences, if any.

Interventions

DIAGNOSTIC_TESTVidiac Score

Vidiac score is a scoring system created according to the visibility of laryngeal structures under videolarnyngoscopy in patients with expected difficult intubation.

Sponsors

Ankara City Hospital Bilkent
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* All obese and morbidly obese patients to be operated under general anesthesia and endotracheal intubation

Exclusion criteria

1. under 18 years old 2. The patient's refusal 3. Difficult airway story before 4. Congenital or previous airway anatomical disorder 5. Patients who have undergone airway surgery 6. Patients with a mass in the head and neck region 7. Body mass ındex \< 30 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
vidiac scoreduring entubationVidiac score is a scoring system created according to the visibility of laryngeal structures under videoingoscopy in patients with expected difficult intubation.

Countries

Turkey (Türkiye)

Contacts

Primary ContactBetül Güven Aytaç, MD
drbguven@hotmail.com+905073578351

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026